By using a variety of gain-of-function of Tollip in vivo and in vitro approaches, our current study demonstrated that Tollip was an independent prognostic indicator for HCC management, which showed an upregulation of Tollip in HCC tissues and exhibited the clinical significance and functional regulation in tumorigenesis. The gene discussed is TOLLIP; the disease is hepatocellular carcinoma.